Shots: Oxford Biomedica has joined the consortium, which is led by the Jenner Institute, University of Oxford and also includes the VMIC, Pall Life Sciences, Cobra Biologics, and Halix BV to rapidly develop, scale-up and manufacture a vaccine (ChAdOx1 nCov-19) against COVID-19 The ChAdOx1 nCOV-19 vaccine is anticipated to be the UK’s first COVID-19 vaccine […]Read More
Tags : Joins
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Regeneron
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US